e-learning
resources
Munich 2014
Sunday, 07.09.2014
COPD exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LATE-BREAKING ABSTRACT: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection.
M. de Vries, N. Bedke, N. P. Smithers, P. H. Howarth, M. C. Nawijn, D. E. Davies (Groningen, Netherlands; Southampton, United Kingdom)
Source:
International Congress 2014 – COPD exacerbations
Session:
COPD exacerbations
Session type:
Poster Discussion
Number:
519
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. de Vries, N. Bedke, N. P. Smithers, P. H. Howarth, M. C. Nawijn, D. E. Davies (Groningen, Netherlands; Southampton, United Kingdom). LATE-BREAKING ABSTRACT: Inhibition of Pim1 kinase augments the anti-viral response to rhinovirus infection.. Eur Respir J 2014; 44: Suppl. 58, 519
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014
Different roles for PI3Kgamma and δ in asthma
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
LATE-BREAKING ABSTRACT: Airway recruitment and anti-viral function of dendritic cells in asthmatic patients during RV-16 infection
Source: International Congress 2016 – Emerging concepts in lung disease pathogenesis
Year: 2016
LSC 2014 abstract - Targeting of microRNAs can restore innate anti-viral response in asthma
Source: International Congress 2014 – Novel epigenetic regulators for targeting via nanomedicine
Year: 2014
TNF alpha promotes coxsackie and adenovirus receptor (CAR) phosphorylation by PKC delta to drive leukocyte transepithelial migration
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Protein tyrosine phosphatase PTPRR regulates PP2A in mononuclear cells
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
LATE-BREAKING ABSTRACT: Airway remodelling induced by ADAM33 is reversible
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
LATE-BREAKING ABSTRACT: IL-5-induced airways eosinophilia as a negative regulator of TLR7 expression may impair the interferon response to rhinovirus in allergic airways
Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment
Year: 2014
Modulation of PD-1 and PD-L1 expression in response to acute viral infection of human lung tissue
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Enhanced inflammatory gene expression in bronchial epithelial cells from asthmatic patients: Attenuation by a Brd4 mimic
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
LATE-BREAKING ABSTRACT: The use of in vitro Human Airway Epithelia for the development of novel antivirals against human rhinoviruses (HRV)
Source: International Congress 2014 – Respiratory infections in children
Year: 2014
Omalizumab prevents smooth muscle cell growth induced by asthmatic serum
Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases
Year: 2014
A role for the WFDC protein, WAP2, in regulation of innate host defence in the lung
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
LATE-BREAKING ABSTRACT: Increased IL-33 expression is related to high levels of TLR-2 and -4 in steroid-free subjects with asthma
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Aerobic exercise training reduces asthma phenotype via inhibition of accumulation of extracellular ATP mediated by P2X7 receptor
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014
Induction of galectin-9 production by viral infection in the lung
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
The polyamine spermine inhibits mitochondrial permeability transition (mPT) and apoptosis in human eosinophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
LATE-BREAKING ABSTRACT: The critical role of interferon-gamma signaling in the respiratory immune response to influenza infection
Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment
Year: 2013
LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation
Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment
Year: 2015
LATE-BREAKING ABSTRACT: E-cigarette exposure induces pathological responses that result in lung tissue destruction and airway hyper reactivity in mice.
Source: International Congress 2014 – E-cigarettes in different populations
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept